Cerebrospinal fluid tumour markers patients meningeal malignancy results cerebrospinal fluid CSF biochemical markers conventional CSF cytology patients leptomeningeal metastases extra cranial malignancies lumbar CSF treatment significant difference probabilities positive CSF cytology classification linear discriminant analysis patient age beta-glucuronidase beta treatment classification linear discriminant analysis positive cytology Possible mechanisms difference ventricular CSF correlation CSF cytology beta-glucuronidase solid tumours CSF cytology beta haematological malignancies Reference values ventricular protein CEA beta-glucuronidase cytological negative samples 